Comprehensive bioanalytical service support is key at every stage of product development in discovery, preclinical and clinical programs. Our worldwide bioanalytical laboratories use a range of techniques and technology platforms to ensure that we can support you with rapid lead-in times in order to meet critical deadlines.

Our experienced scientists develop, validate and apply quantitative methods to measure drug and metabolite concentrations for samples in plasma, serum, cerebrospinal fluid (CSF), urine and tissue. Our comprehensive services can be performed on small molecules and large molecules, including antibody-drug conjugates, biosimilars, monoclonal antibodies, oligonucleotides, peptides, proteins and vaccines.

Webinar Series: The Path to First-in-Human

Examine practical and scientific aspects relating to the three key steps from discovery to initiating clinical trials.

Register Here »

You may also be interested in...

automatic pipettes

AAPS 2016

Check out the highlights from our presence at this year’s conference in Boston.